Sensitivity of human pluripotent stem cells to insulin precipitation induced by peristaltic pump-based medium circulation: Considerations on process development

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autorschaft

  • Diana Massai
  • Emiliano Bolesani
  • Diana Robles Diaz
  • Christina Kropp
  • Henning Kempf
  • Caroline Halloin
  • Ulrich Martin
  • Tudor Braniste
  • Giuseppe Isu
  • Vanessa Harms
  • Umberto Morbiducci
  • Gerald Dräger
  • Robert Zweigerdt

Organisationseinheiten

Externe Organisationen

  • Leibniz Forschungslaboratorien für Biotechnologie und künstliche Organe (LEBAO)
  • REBIRTH Forschungszentrum für translationale regenerative Medizin
  • Technical University of Moldova
  • Politecnico di Torino (POLITO)
  • University Hospital of Basel
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Aufsatznummer3950
Seitenumfang15
FachzeitschriftScientific Reports
Jahrgang7
Ausgabenummer1
Frühes Online-Datum21 Juni 2017
PublikationsstatusVeröffentlicht - Dez. 2017

Abstract

Controlled large-scale production of human pluripotent stem cells (hPSCs) is indispensable for their envisioned clinical translation. Aiming at advanced process development in suspension culture, the sensitivity of hPSC media to continuous peristaltic pump-based circulation, a well-established technology extensively used in hydraulically-driven bioreactors, was investigated. Unexpectedly, conditioning of low protein media (i.e. E8 and TeSR-E8) in a peristaltic pump circuit induced severe viability loss of hPSCs cultured as aggregates in suspension. Optical, biochemical, and cytological analyses of the media revealed that the applied circulation mode resulted in the reduction of the growth hormone insulin by precipitation of micro-sized particles. Notably, in contrast to insulin depletion, individual withdrawal of other medium protein components (i.e. bFGF, TGFβ1 or transferrin) provoked minor reduction of hPSC viability, if any. Supplementation of the surfactant glycerol or the use of the insulin analogue Aspart did not overcome the issue of insulin precipitation. In contrast, the presence of bovine or human serum albumin (BSA or HSA, respectively) stabilized insulin rescuing its content, possibly by acting as molecular chaperone-like protein, ultimately supporting hPSC maintenance. This study highlights the potential and the requirement of media optimization for automated hPSC processing and has broad implications on media development and bioreactor-based technologies.

ASJC Scopus Sachgebiete

Zitieren

Sensitivity of human pluripotent stem cells to insulin precipitation induced by peristaltic pump-based medium circulation: Considerations on process development. / Massai, Diana; Bolesani, Emiliano; Robles Diaz, Diana et al.
in: Scientific Reports, Jahrgang 7, Nr. 1, 3950, 12.2017.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Massai, D, Bolesani, E, Robles Diaz, D, Kropp, C, Kempf, H, Halloin, C, Martin, U, Braniste, T, Isu, G, Harms, V, Morbiducci, U, Dräger, G & Zweigerdt, R 2017, 'Sensitivity of human pluripotent stem cells to insulin precipitation induced by peristaltic pump-based medium circulation: Considerations on process development', Scientific Reports, Jg. 7, Nr. 1, 3950. https://doi.org/10.1038/s41598-017-04158-x
Massai, D., Bolesani, E., Robles Diaz, D., Kropp, C., Kempf, H., Halloin, C., Martin, U., Braniste, T., Isu, G., Harms, V., Morbiducci, U., Dräger, G., & Zweigerdt, R. (2017). Sensitivity of human pluripotent stem cells to insulin precipitation induced by peristaltic pump-based medium circulation: Considerations on process development. Scientific Reports, 7(1), Artikel 3950. https://doi.org/10.1038/s41598-017-04158-x
Massai D, Bolesani E, Robles Diaz D, Kropp C, Kempf H, Halloin C et al. Sensitivity of human pluripotent stem cells to insulin precipitation induced by peristaltic pump-based medium circulation: Considerations on process development. Scientific Reports. 2017 Dez;7(1):3950. Epub 2017 Jun 21. doi: 10.1038/s41598-017-04158-x
Download
@article{7f860d1b45a649b598649af1df8e45de,
title = "Sensitivity of human pluripotent stem cells to insulin precipitation induced by peristaltic pump-based medium circulation: Considerations on process development",
abstract = "Controlled large-scale production of human pluripotent stem cells (hPSCs) is indispensable for their envisioned clinical translation. Aiming at advanced process development in suspension culture, the sensitivity of hPSC media to continuous peristaltic pump-based circulation, a well-established technology extensively used in hydraulically-driven bioreactors, was investigated. Unexpectedly, conditioning of low protein media (i.e. E8 and TeSR-E8) in a peristaltic pump circuit induced severe viability loss of hPSCs cultured as aggregates in suspension. Optical, biochemical, and cytological analyses of the media revealed that the applied circulation mode resulted in the reduction of the growth hormone insulin by precipitation of micro-sized particles. Notably, in contrast to insulin depletion, individual withdrawal of other medium protein components (i.e. bFGF, TGFβ1 or transferrin) provoked minor reduction of hPSC viability, if any. Supplementation of the surfactant glycerol or the use of the insulin analogue Aspart did not overcome the issue of insulin precipitation. In contrast, the presence of bovine or human serum albumin (BSA or HSA, respectively) stabilized insulin rescuing its content, possibly by acting as molecular chaperone-like protein, ultimately supporting hPSC maintenance. This study highlights the potential and the requirement of media optimization for automated hPSC processing and has broad implications on media development and bioreactor-based technologies.",
author = "Diana Massai and Emiliano Bolesani and {Robles Diaz}, Diana and Christina Kropp and Henning Kempf and Caroline Halloin and Ulrich Martin and Tudor Braniste and Giuseppe Isu and Vanessa Harms and Umberto Morbiducci and Gerald Dr{\"a}ger and Robert Zweigerdt",
note = "Publisher Copyright: {\textcopyright} 2017 The Author(s). Copyright: Copyright 2017 Elsevier B.V., All rights reserved.",
year = "2017",
month = dec,
doi = "10.1038/s41598-017-04158-x",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

Download

TY - JOUR

T1 - Sensitivity of human pluripotent stem cells to insulin precipitation induced by peristaltic pump-based medium circulation

T2 - Considerations on process development

AU - Massai, Diana

AU - Bolesani, Emiliano

AU - Robles Diaz, Diana

AU - Kropp, Christina

AU - Kempf, Henning

AU - Halloin, Caroline

AU - Martin, Ulrich

AU - Braniste, Tudor

AU - Isu, Giuseppe

AU - Harms, Vanessa

AU - Morbiducci, Umberto

AU - Dräger, Gerald

AU - Zweigerdt, Robert

N1 - Publisher Copyright: © 2017 The Author(s). Copyright: Copyright 2017 Elsevier B.V., All rights reserved.

PY - 2017/12

Y1 - 2017/12

N2 - Controlled large-scale production of human pluripotent stem cells (hPSCs) is indispensable for their envisioned clinical translation. Aiming at advanced process development in suspension culture, the sensitivity of hPSC media to continuous peristaltic pump-based circulation, a well-established technology extensively used in hydraulically-driven bioreactors, was investigated. Unexpectedly, conditioning of low protein media (i.e. E8 and TeSR-E8) in a peristaltic pump circuit induced severe viability loss of hPSCs cultured as aggregates in suspension. Optical, biochemical, and cytological analyses of the media revealed that the applied circulation mode resulted in the reduction of the growth hormone insulin by precipitation of micro-sized particles. Notably, in contrast to insulin depletion, individual withdrawal of other medium protein components (i.e. bFGF, TGFβ1 or transferrin) provoked minor reduction of hPSC viability, if any. Supplementation of the surfactant glycerol or the use of the insulin analogue Aspart did not overcome the issue of insulin precipitation. In contrast, the presence of bovine or human serum albumin (BSA or HSA, respectively) stabilized insulin rescuing its content, possibly by acting as molecular chaperone-like protein, ultimately supporting hPSC maintenance. This study highlights the potential and the requirement of media optimization for automated hPSC processing and has broad implications on media development and bioreactor-based technologies.

AB - Controlled large-scale production of human pluripotent stem cells (hPSCs) is indispensable for their envisioned clinical translation. Aiming at advanced process development in suspension culture, the sensitivity of hPSC media to continuous peristaltic pump-based circulation, a well-established technology extensively used in hydraulically-driven bioreactors, was investigated. Unexpectedly, conditioning of low protein media (i.e. E8 and TeSR-E8) in a peristaltic pump circuit induced severe viability loss of hPSCs cultured as aggregates in suspension. Optical, biochemical, and cytological analyses of the media revealed that the applied circulation mode resulted in the reduction of the growth hormone insulin by precipitation of micro-sized particles. Notably, in contrast to insulin depletion, individual withdrawal of other medium protein components (i.e. bFGF, TGFβ1 or transferrin) provoked minor reduction of hPSC viability, if any. Supplementation of the surfactant glycerol or the use of the insulin analogue Aspart did not overcome the issue of insulin precipitation. In contrast, the presence of bovine or human serum albumin (BSA or HSA, respectively) stabilized insulin rescuing its content, possibly by acting as molecular chaperone-like protein, ultimately supporting hPSC maintenance. This study highlights the potential and the requirement of media optimization for automated hPSC processing and has broad implications on media development and bioreactor-based technologies.

UR - http://www.scopus.com/inward/record.url?scp=85021200412&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-04158-x

DO - 10.1038/s41598-017-04158-x

M3 - Article

C2 - 28638147

AN - SCOPUS:85021200412

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 3950

ER -

Von denselben Autoren